Organ differences in the enhancing potential of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on carcinogenicity in the prostate, colon and pancreas.

[1]  K. Imaida,et al.  Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats. , 2002, Carcinogenesis.

[2]  K. Imaida,et al.  Organ dependent enhancement of rat 3,2'-dimethyl-4-aminobiphenyl (DMAB) carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): positive effects on the intestine but not the prostate. , 2001, Carcinogenesis.

[3]  R C Garner,et al.  Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. , 2000, Mutation research.

[4]  B. Magnuson,et al.  Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci. , 2000, Cancer letters.

[5]  M Kulldorff,et al.  2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. , 2000, Journal of the National Cancer Institute.

[6]  M. Inoue,et al.  More Frequent β‐Catenin Gene Mutations in Adenomas than in Aberrant Crypt Foci or Adenocarcinomas in the Large Intestines of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP)‐treated Rats , 2000, Japanese journal of cancer research : Gann.

[7]  Satoru Takahashi,et al.  Immunohistochemical Detection of Carcinogen‐DNA Adducts in Normal Human Prostate Tissues Transplanted into the Subcutis of Athymic Nude Mice: Results with 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) and 3,2′‐Dimethyl‐4‐aminobiphenyl (DMAB) and Relation to Cytochrome P450s and N‐Acetyltran , 2000, Japanese journal of cancer research : Gann.

[8]  T. Shirai,et al.  Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate. , 1999, Cancer letters.

[9]  K. Turteltaub,et al.  DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  S. Schwartz,et al.  Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. , 1999, The Journal of urology.

[11]  T. Shirai,et al.  Use of polyclonal antibodies against carcinogen-DNA adducts in analysis of carcinogenesis. , 1998, Toxicology letters.

[12]  M. Hirose,et al.  Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. , 1998, Cancer research.

[13]  T. Sugimura,et al.  High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. , 1998, Cancer research.

[14]  H. Esumi,et al.  Modification by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) of 3,2'-dimethyl-4-aminobiphenyl (DMAB)-induced rat pancreatic and intestinal tumorigenesis. , 1998, Cancer letters.

[15]  K. Imaida,et al.  Medium-term Rat Liver Bioassay for Rapid Detection of Hepatocarcinogenic Substances , 1997 .

[16]  N Ito,et al.  The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. , 1997, Cancer research.

[17]  Ryohei Hasegawa,et al.  Dose‐dependent Induction of Mammary Carcinomas in Female Sprague‐Dawley Rats with 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine , 1996, Japanese journal of cancer research : Gann.

[18]  T. Shirai,et al.  DNA adducts in target and nontarget tissues of 3,2'-dimethyl-4-aminobiphenyl in rats. , 1994, Environmental health perspectives.

[19]  N Ito,et al.  Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) carcinogenicity in rats. , 1993, Carcinogenesis.

[20]  L B Fay,et al.  Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings. , 1993, Carcinogenesis.

[21]  T. Sugimura,et al.  Exposure to heterocyclic amines. , 1993, Environmental health perspectives.

[22]  N Ito,et al.  A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1991, Carcinogenesis.

[23]  T. Sugimura,et al.  Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. , 1991, Carcinogenesis.

[24]  S. Fukushima,et al.  Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. , 1991, Carcinogenesis.

[25]  T. Sugimura,et al.  Heterocyclic amines: new mutagens and carcinogens in cooked foods. , 1991, Advances in experimental medicine and biology.

[26]  S. Fukushima,et al.  Immunohistochemical demonstration of carcinogen-DNA adducts in target and non-target tissues of rats given a prostate carcinogen, 3,2'-dimethyl-4-aminobiphenyl. , 1990, Carcinogenesis.

[27]  S. Fukushima,et al.  Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2'-dimethyl-4-aminobiphenyl. , 1988, Cancer research.

[28]  F. Hatch,et al.  The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1986, Carcinogenesis.

[29]  S. Fukushima,et al.  Rat prostate as one of the target organs for 3,2'-dimethyl-4-aminobiphenyl-induced carcinogenesis: effects of dietary ethinyl estradiol and methyltestosterone. , 1985, Japanese journal of cancer research : Gann.

[30]  E. Longstaff,et al.  Initiation/promotion versus complete carcinogenicity in the rodent liver , 1983, Environmental health perspectives.

[31]  R. Möhlmann,et al.  Proliferation-stimulating effect of phenacetin on the urothelium and papillary epithelium of rats. , 1983, Urologia internationalis.

[32]  E. Kunze,et al.  Absence of a complete carcinogenic effect of phenacetin on the quiescent and proliferating urothelium stimulated by partial cystectomy. A 2-year feeding study in rats. , 1983, Urologia internationalis.

[33]  H. Zerban,et al.  Biological markers of preneoplastic foci and neoplastic nodules in rodent liver * , 1982, Toxicologic pathology.

[34]  K. Imaida,et al.  Sequential observation of pathomorphologic alterations in preneoplastic lesions during the promoting stage of hepatocarcinogenesis and the development of short-term test system for hepatopromoters and hepatocarcinogens , 1982, Toxicologic pathology.

[35]  I. Berenblum,et al.  The Role of Croton Oil Applications, Associated with a Single Painting of a Carcinogen, in Tumour Induction of the Mouse's Skin , 1947, British Journal of Cancer.